123 related articles for article (PubMed ID: 2465010)
21. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue.
Hobisch A; Rogatsch H; Hittmair A; Fuchs D; Bartsch G; Klocker H; Bartsch G; Culig Z
J Pathol; 2000 Jul; 191(3):239-44. PubMed ID: 10878544
[TBL] [Abstract][Full Text] [Related]
23. Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.
Turhan OI; Aydin NE; Sariyüce O; Ozkan S
Int Urol Nephrol; 1998; 30(6):731-44. PubMed ID: 10195869
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical demonstration of cytokeratins in the human prostate.
Wernert N; Seitz G; Goebbels R; Dhom G
Pathol Res Pract; 1986 Dec; 181(6):668-74. PubMed ID: 2436199
[TBL] [Abstract][Full Text] [Related]
25. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
Botticelli AR
Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
[TBL] [Abstract][Full Text] [Related]
26. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.
Verhagen AP; Ramaekers FC; Aalders TW; Schaafsma HE; Debruyne FM; Schalken JA
Cancer Res; 1992 Nov; 52(22):6182-7. PubMed ID: 1384957
[TBL] [Abstract][Full Text] [Related]
27. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
28. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues.
Varma M; Linden MD; Amin MB
Mod Pathol; 1999 May; 12(5):472-8. PubMed ID: 10349984
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma.
Wernert N; Seitz G; Achtstätter T
Pathol Res Pract; 1987 Oct; 182(5):617-26. PubMed ID: 2446293
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
31. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
Helpap B; Köllermann J; Oehler U
J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
[TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.
Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ
In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042
[TBL] [Abstract][Full Text] [Related]
33. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
[TBL] [Abstract][Full Text] [Related]
34. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
36. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
37. Metallothionein expression in human prostate gland.
Bataineh ZM; Nusier MK
Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
[TBL] [Abstract][Full Text] [Related]
38. Minimal adenocarcinoma in prostate needle biopsy tissue.
Thorson P; Humphrey PA
Am J Clin Pathol; 2000 Dec; 114(6):896-909. PubMed ID: 11338479
[TBL] [Abstract][Full Text] [Related]
39. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
Garcia FU; Haber MM; Chen X
Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
[TBL] [Abstract][Full Text] [Related]
40. Augmented expression of chromogranin A and serotonin in peri-malignant benign prostate epithelium as compared to adenocarcinoma.
Sion-Vardy N; Tzikinovsky A; Bolotyn A; Segal S; Fishman D
Pathol Res Pract; 2004; 200(7-8):493-9. PubMed ID: 15462496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
